Medical Properties Company Insiders
MPW Stock | USD 4.40 0.05 1.12% |
Slightly above 84 percent of Medical Properties' insiders are selling. The analysis of insiders' sentiment of trading Medical Properties Trust stock suggests that a fairly large number of insiders are terrified at this time. Medical Properties employs about 121 people. The company is managed by 20 executives with a total tenure of roughly 143 years, averaging almost 7.0 years of service per executive, having 6.05 employees per reported executive.
Edward Aldag Chairman Co-Founder, Chairman, CEO and President and Chairman of Investment Committee |
Emmett McLean President Chief Operating Officer, Executive Vice President, Secretary |
Medical Properties' Insider Buying Vs Selling
16
Selling | Buying |
Latest Trades
2024-12-26 | James Kevin Hanna | Disposed 11641 @ 3.72 | View | ||
2024-12-23 | Rosa Handley Hooper | Disposed 3000 @ 3.67 | View | ||
2024-10-09 | Michael G Stewart | Disposed 32780 @ 5.46 | View | ||
2024-09-18 | Elizabeth N Pitman | Acquired 8087 @ 6.01 | View | ||
2024-08-27 | C Reynolds Thompson III | Disposed 20530 @ 4.38 | View | ||
2024-08-15 | Elizabeth N Pitman | Disposed 10025 @ 4.98 | View |
Monitoring Medical Properties' insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Medical |
Medical Properties' Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Medical Properties' future performance. Based on our forecasts, it is anticipated that Medical will maintain a workforce of slightly above 120 employees by March 2025.Medical Properties' latest congressional trading
Congressional trading in companies like Medical Properties Trust, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in Medical Properties by those in governmental positions are based on the same information available to the general public.
2022-03-13 | Representative Pete Sessions | Acquired Under $15K | Verify | ||
2017-03-02 | Senator Gary Peters | Acquired Under $15K | Verify | ||
2017-03-01 | Senator Gary Peters | Acquired Under $15K | Verify |
Medical Properties Management Team Effectiveness
Return On Tangible Assets is likely to climb to -0.03 in 2025. Return On Capital Employed is likely to drop to 0.01 in 2025. At this time, Medical Properties' Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 1.5 B in 2025, whereas Other Current Assets are likely to drop slightly above 378 M in 2025. Medical Properties' management efficiency ratios could be used to measure how well Medical Properties manages its routine affairs as well as how well it operates its assets and liabilities.Common Stock Shares Outstanding is likely to climb to about 722.7 M in 2025. Net Income Applicable To Common Shares is likely to climb to about 1.1 B in 2025
Medical Properties Workforce Comparison
Medical Properties Trust is regarded fifth in number of employees category among its peers. The total workforce of Real Estate industry is now estimated at about 1,811. Medical Properties holds roughly 121 in number of employees claiming about 7% of equities listed under Real Estate industry.
Medical Properties Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medical Properties insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medical Properties' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Medical Properties insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-09-01 | 0.125 | 1 | 8 | 8,087 | 109,396 |
2024-03-01 | 4.2 | 21 | 5 | 4,423,997 | 35,292 |
2023-12-01 | 0.6 | 3 | 5 | 600,000 | 51,591 |
2023-09-01 | 1.0 | 6 | 6 | 209,864 | 53,725 |
2023-06-01 | 0.75 | 3 | 4 | 17,760 | 496.00 |
2023-03-01 | 2.0833 | 25 | 12 | 2,057,660 | 423,665 |
2022-09-01 | 0.25 | 1 | 4 | 10,000 | 41,141 |
2022-03-01 | 3.8333 | 23 | 6 | 2,806,935 | 1,800,272 |
2021-03-01 | 9.3333 | 28 | 3 | 2,250,012 | 993,000 |
2020-03-01 | 28.0 | 28 | 1 | 2,503,665 | 100,000 |
2019-12-01 | 2.5 | 5 | 2 | 274,543 | 106,764 |
2019-09-01 | 0.25 | 1 | 4 | 7,476 | 254,976 |
2019-03-01 | 3.4 | 17 | 5 | 761,785 | 444,048 |
2018-12-01 | 0.75 | 3 | 4 | 411,641 | 111,265 |
2018-09-01 | 0.2 | 1 | 5 | 5,662 | 159,071 |
2018-03-01 | 0.75 | 3 | 4 | 298,236 | 606,187 |
2017-06-01 | 6.0 | 6 | 1 | 1,243,767 | 85,000 |
2017-03-01 | 3.0 | 9 | 3 | 80,841 | 353,115 |
2016-09-01 | 4.3333 | 13 | 3 | 896,767 | 60,000 |
2016-06-01 | 1.0 | 5 | 5 | 37,940 | 347,000 |
2016-03-01 | 0.3333 | 1 | 3 | 7,588 | 245,627 |
2015-09-01 | 0.3333 | 1 | 3 | 3,000 | 39,576 |
2015-03-01 | 4.3333 | 13 | 3 | 899,273 | 204,656 |
2014-06-01 | 0.2 | 1 | 5 | 20,000 | 119,760 |
2014-03-01 | 11.0 | 11 | 1 | 958,936 | 600,000 |
2013-03-01 | 1.1667 | 14 | 12 | 1,054,680 | 125,446 |
2012-12-01 | 0.0074 | 1 | 135 | 41,748 | 789,248 |
2012-03-01 | 0.75 | 9 | 12 | 1,039,083 | 90,000 |
2011-09-01 | 3.0 | 3 | 1 | 500,000 | 2,182 |
2011-03-01 | 4.0 | 8 | 2 | 415,853 | 21,000 |
2010-12-01 | 3.0 | 6 | 2 | 270,000 | 3,000 |
2010-03-01 | 8.5 | 17 | 2 | 710,790 | 10,000 |
2009-06-01 | 1.0 | 4 | 4 | 26,752 | 26,752 |
2009-03-01 | 5.25 | 21 | 4 | 430,531 | 10,600 |
2008-12-01 | 4.0 | 4 | 1 | 1,548 | 9,000 |
2008-09-01 | 0.4444 | 4 | 9 | 1,154 | 81,000 |
2008-06-01 | 0.5 | 4 | 8 | 1,032 | 81,000 |
2008-03-01 | 9.5 | 19 | 2 | 436,524 | 5,136 |
2007-12-01 | 5.0 | 5 | 1 | 2,364 | 2,622 |
2006-03-01 | 8.0 | 8 | 1 | 88,988 | 1,000.00 |
2005-09-01 | 2.0 | 8 | 4 | 250,060 | 0.00 |
Medical Properties Notable Stakeholders
A Medical Properties stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Medical Properties often face trade-offs trying to please all of them. Medical Properties' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Medical Properties' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Steven CPA | Executive Founder | Profile | |
Larry Portal | Senior CEO | Profile | |
Edward Aldag | Co-Founder, Chairman, CEO and President and Chairman of Investment Committee | Profile | |
Emmett McLean | Chief Operating Officer, Executive Vice President, Secretary | Profile | |
Steven Hamner | Chief Financial Officer, Executive Vice President, Director | Profile | |
R Hamner | Chief Financial Officer, Executive Vice President, Director | Profile | |
Caterina Mozingo | Independent Director | Profile | |
Michael Stewart | Lead Independent Director | Profile | |
Daniel Sparks | Independent Director | Profile | |
Tim Berryman | Director of Investor Relations | Profile | |
Elizabeth Pitman | Independent Director | Profile | |
G Dawson | Independent Director | Profile | |
Emily Murphy | Independent Director | Profile | |
Jamey Ramsey | Managing Tax | Profile | |
Charles Lambert | Treasurer VP | Profile | |
Andrew CFA | Senior Communications | Profile | |
Rosa Hooper | Assistant Operations | Profile | |
James Hanna | VP Officer | Profile | |
Lucas Savage | VP Acquisitions | Profile | |
C Thompson | Independent Director | Profile |
About Medical Properties Management Performance
The success or failure of an entity such as Medical Properties Trust often depends on how effective the management is. Medical Properties management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Medical management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Medical management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.03) | (0.03) | |
Return On Capital Employed | 0.01 | 0.01 | |
Return On Assets | (0.04) | (0.03) | |
Return On Equity | (0.07) | (0.06) |
Please note, the imprecision that can be found in Medical Properties' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Medical Properties Trust. Check Medical Properties' Beneish M Score to see the likelihood of Medical Properties' management manipulating its earnings.
Medical Properties Workforce Analysis
Traditionally, organizations such as Medical Properties use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Medical Properties within its industry.Medical Properties Manpower Efficiency
Return on Medical Properties Manpower
Revenue Per Employee | 7.2M | |
Revenue Per Executive | 43.6M | |
Net Loss Per Employee | 4.6M | |
Net Loss Per Executive | 27.8M |
Additional Tools for Medical Stock Analysis
When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.